• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
7,8-Dihydroxyflavone Hydrate

7,8-Dihydroxyflavone Hydrate

Product ID D3329
Cas No. 38183-03-8
Purity ≥99%
Product Unit SizeCostQuantityStock
25 mg $59.30 In stock
100 mg $84.40 In stock
500 mg $270.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

7,8-Dihydroxyflavone (DHF) is a brain-derived neurotrophic factor (BDNF) mimetic that activates TrkB receptors. DHF displays neuromodulatory, neuroprotective, antipsychotic, anti-obesity, anticancer, antioxidative, anti-inflammatory, and antihypertensive activities. In animal models of traumatic brain injury (TBI), DHF decreases brain edema, neuronal death, and brain tissue damage and improves functional deficits. In animal models of schizophrenia, this compound reverses cognitive deficits and promotes synaptic plasticity. DHF also benefits neurodegenerative disease models such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS); in these models, DHF decreases motor deficits and improves cognitive abilities. DHF prevents the induction of diet-induced obesity in animal models and also decreases adiposity, increases energy expenditure, and improves insulin sensitivity in already-obese animals. In oral squamous cell carcinoma cells, this compound decreases cell growth and induces apoptosis by suppressing Sp1 signaling. DHF also decreases production of NO and PGE2 and suppresses expression of COX-2, iNOS, TNF-α, and IL-1β in LPS-stimulated microglia. In other cellular models, DHF increases levels of HO-1 and Nrf2, protecting against H2O2- and UV light-induced oxidative damage. DHF also increases eNOS expression in vitro and decreases blood pressure in spontaneously hypertensive rats.

Product Info

Cas No.

38183-03-8

Purity

≥99%

Formula

C15H10O4 • xH2O

Formula Wt.

254.24 (anhy)

IUPAC Name

7,8-Dihydroxy-2-phenyl-4H-chromen-4-one

Solubility

DMSO: 24 mg/mL

Appearance

Yellow powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

D3329 MSDS PDF

Info Sheet

D3329 Info Sheet PDF

References

Chan CB, Tse MC, Liu X, et al. Activation of Muscular TrkB by its Small Molecular Agonist 7,8-Dihydroxyflavone Sex-Dependently Regulates Energy Metabolism in Diet-Induced Obese Mice. 2015 Mar 19;22(3):355-68. PMID: 25754472.

Sconce MD, Churchill MJ, Moore C, et al. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease. Neuroscience. 2015 Apr 2;290:454-71. PMID: 25655214.

Lee RH, Shin JC, Kim KH, et al. Apoptotic effects of 7,8-dihydroxyflavone in human oral squamous cancer cells through suppression of Sp1. Oncol Rep. 2015 Feb;33(2):631-8. PMID: 25434704.

Wu CH, Hung TH, Chen CC, et al. Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling. PLoS One. 2014 Nov 21;9(11):e113397. PMID: 25415296.

Yang YJ, Li YK, Wang W, et al. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Pharmacol Biochem Behav. 2014 Jul;122:30-6. PMID: 24662915.

Korkmaz OT, Aytan N, Carreras I, et al. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neurosci Lett. 2014 Apr 30;566:286-91. PMID: 24637017.

Park HY, Park C, Hwang HJ, et al. 7,8-Dihydroxyflavone attenuates the release of pro-inflammatory mediators and cytokines in lipopolysaccharide-stimulated BV2 microglial cells through the suppression of the NF-κB and MAPK signaling pathways. Int J Mol Med. 2014 Apr;33(4):1027-34. PMID: 24535427.

Ryu MJ, Kang KA, Piao MJ, et al. 7,8-Dihydroxyflavone protects human keratinocytes against oxidative stress-induced cell damage via the ERK and PI3K/Akt-mediated Nrf2/HO-1 signaling pathways. Int J Mol Med. 2014 Apr;33(4):964-70. PMID: 24503931.

Castello NA, Nguyen MH, Tran JD, et al. 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS One. 2014 Mar 10;9(3):e91453. PMID: 24614170.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A064766

    ABT 639

    T-type calcium channel blocker

    ≥99%
  • P0146

    Palmitoyl-L-carnitine

    Long chain acylcarnitine involved in fatty acid...

    ≥98%
  • T1674

    Terbutaline Sulfate

    β2-adrenergic agonist, potential ENaC activato...

    ≥98%
  • T1652

    Teniposide

    Podophyllotoxin derivative; topoisomerase II in...

    ≥97%
  • D5611

    Docosahexaenoic Acid (all cis-4,7,10,13,16,19) Methyl Ester

    Essential fatty acid found in fish oil, involve...

    ≥99%
  • M4455

    MLN-2238

    Proteasome inhibitor, miR33b modulator.

    ≥95%
  • C000078

    C-178

    STING inhibitor

    ≥99%
  • K624760

    KPT-276

    CRM1/XPO1 inhibitor.

    ≥99%
  • F1670

    Ferulic Acid Methyl Ester

    Hydroxycinnamic aicd, verbascoside metabolite, ...

    ≥98%
  • C9863

    Cyproconazole

    Triazole; 14-α demethylase inhibitor, voltage-...

    ≥95%
  • V0245

    Valdecoxib

    NSAID; CB1 agonist, COX-2 inhibitor.

    ≥98%
  • T165133

    Tedizolid Phosphate

    Effective against gram-positive pathogens

    ≥98%
  • S1968

    Seratrodast

    TxA2 antagonist.

    ≥99%
  • C8112

    CUDC-907

    PI3K and HDAC inhibitor.

    ≥98%
  • R1879

    Retinyl Palmitate

    Vitamin A derivative, palmitic acid ester of re...

    ≥1.70 MIU/g, bio assay
  • T1953

    Tenovin-3

    Potential p53 activator or SIRT2 inhibitor.

    ≥98%
  • G4596

    Glycidamide

    Epoxide metabolite of acrylamide, induces DNA a...

    ≥98%
  • W9602

    WY-14643

    A peroxisome proliferator-activated receptor ag...

    ≥98%
  • T7676

    HT-2 Toxin

    Trichothecene mycotoxin produced by Fusarium.

    ≥98%, TLC, HPLC
  • A686164

    Arecaidine Hydrochloride

    mAChR agonist, selective for M2.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only